Malaysian Sovereign Wealth Backs Bay Area Pharma Company
Posted on 08/10/2016
Increasingly, Asian wealth funds continue to make larger inroads into the U.S. pharmaceutical industry by backing emerging companies. [private_standard]Iconic Therapeutics, a South San Francisco-based clinical stage biopharmaceutical company, finished a Series C round at US$ 48.5 million. US$ 10 million was kicked in by Malaysia-based Xeraya Capital Sdn Berhad, an investor backed by Malaysia’s Khazanah […]
- Alternatives
- Asia
- Germany
- healthcare
- Iconic Pharmaceuticals
- Khazanah
- Malaysia
- North America
- retinal
- United States
